AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « option »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
optimizing < option < options  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000016 (2020) M. SilbersteinVitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000071 (2020) Roos A W. Wennink [Pays-Bas] ; Viera Kalinina Ayuso [Pays-Bas] ; Lieuwe A. De Vries [Pays-Bas] ; Sebastiaan J. Vastert [Pays-Bas] ; Joke H. De Boer [Pays-Bas]Tocilizumab as an Effective Treatment Option in Children with Refractory Intermediate and Panuveitis.
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000087 (2020) Wanhai Ke ; Li Zhang ; Yan DaiThe role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
000134 (2020) Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000194 (2020) Alimuddin Zumla [Royaume-Uni] ; David S. Hui [République populaire de Chine] ; Esam I. Azhar [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Markus Maeurer [Portugal, Allemagne]Reducing mortality from 2019-nCoV: host-directed therapies should be an option
000272 (2020) Jinwen Lin ; Shiping Yu ; Rending Wang ; Jianghua ChenMulticentric Castleman’s disease in a renal allograft recipient: a case report and literature review
000301 (2020) Austin R. Morrison ; Joseph M. Johnson ; Mayur Ramesh ; Patrick Bradley ; Jeffery Jennings ; Zachary R. SmithLetter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
000305 (2020) Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000306 (2020) Grant Broussard [États-Unis] ; Blossom Damania [États-Unis]KSHV: Immune Modulation and Immunotherapy
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000358 (2020) Shike Geng [République populaire de Chine] ; Qing Mei [République populaire de Chine] ; Chunyan Zhu [République populaire de Chine] ; Tianjun Yang [République populaire de Chine] ; Yun Yang [République populaire de Chine] ; Xiaowei Fang [République populaire de Chine] ; Aijun Pan [République populaire de Chine]High flow nasal cannula is a good treatment option for COVID-19
000414 (2020) Guiomar Pinheiro [Portugal] ; Ana Rita Costa [Portugal] ; Ana Campar [Portugal] ; Teresa Mendonça [Portugal]Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports
000420 (2020) Chihiro Iwao [Japon] ; Kunihiko Umekita [Japon] ; Shunichi Miyauchi [Japon] ; Masatoshi Kimura [Japon] ; Yuki Rikitake [Japon] ; Koushou Iwao [Japon] ; Mao Rikitake [Japon] ; Ayako Aizawa [Japon] ; Takeshi Kawaguchi [Japon] ; Yumi Kariya [Japon] ; Motohiro Matsuda [Japon] ; Ichiro Takajo [Japon] ; Kazutaka Shiomi [Japon] ; Akihiko Okayama [Japon]Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
000475 (2020) Farzaneh Dastan [Iran] ; Ali Saffaei [Iran] ; Seyed Mehdi Mortazavi [Iran] ; Hamidreza Jamaati [Iran] ; Nadia Adnani [Iran] ; Sasan Samiee Roudi [Iran] ; Arda Kiani [Iran] ; Atefeh Abedini [Iran] ; Seyed Mohammadreza Hashemian [Iran]Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19
000568 (2020) Charlotte Laurent [France] ; Zora Marjanovic [France] ; Laure Ricard [France] ; Joerg Henes [Allemagne] ; Remy Dulery [France] ; Manuela Badoglio [France] ; Dominique Farge [France] ; John A. Snowden [Royaume-Uni] ; Daniela Moraes [Brésil] ; Juliana Dias [Brésil] ; Mohamad Mohty [France] ; Michael Soussan [France] ; Olivier Fain [France] ; Renate Arnold [Allemagne] ; Tobias Alexander [Allemagne] ; Maria-Carolina Oliveira [Brésil] ; Arsène Mekinian [France]Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
000624 (2015) Raja Atreya [Allemagne] ; Ulrike Billmeier [Allemagne] ; Timo Rath [Allemagne] ; Jonas Mudter [Allemagne] ; Michael Vieth [Allemagne] ; Helmut Neumann [Allemagne] ; Markus F. Neurath [Allemagne]First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.
000632 (????) -. Lombardy Section Italian Society Infectious And Tropical DiseasesVademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "option" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "option" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    option
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021